While there are several bacteria and viruses causing pneumonia, the research team looked specifically at Streptococcus pneumoniae.

EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

Xmoor expects to gain from direct collaboration with UCL’s translational researchers, enabling it to take part in technological innovation.

TY1 enhances the action of TREX1, a gene that helps immune cells clear damaged DNA, helping to minimize scar tissue post heart attacks.

Researchers describe pegcetacoplan, a new class of medication, as the “closest thing to a cure” for the rare, severe kidney disease C3 glomerulopathy.

Researchers employed a technique that can allow the discovery of novel microbiome-produced metabolites not seen under standard laboratory conditions.